Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2026 Jan 29;82(Pt 2):227–230. doi: 10.1107/S205698902600071X

Crystal structure of 2-oxo-2H-chromen-7-yl tri­fluoro­methane­sulfonate

Navneet Goyal a,*, Rafia Rashid a, Xiaodong Zhang b, Abha Verma a, Rami A Al-Horani c, James P Donahue b,*
Editor: J Reibenspiesd
PMCID: PMC12874245  PMID: 41657518

The title compound, 2-oxo-2H-chromen-7-yl-tri­fluoro­methane­sulfonate, crystallizes as closely associated pairs across an inversion center, these dyads then forming steps in a staircase packing arrangement in the direction of the b axis. Efficient crystal packing is assisted by a dense network of C—H⋯O inter­molecular contacts.

Keywords: crystal structure, coumarin, tri­fluoro­methane­sulfonate-substituted

Abstract

Crystalline 2-oxo-2H-chromen-7-yl tri­fluoro­methane­sulfonate, C10H5F3O5S, forms in the monoclinic space group C2/c as pseudoplanar dyads about an inversion center, with close packing assisted by inter­molecular C—H⋯O contacts of 2.38 Å. These dyads are arranged into a staircase pattern where the direction and pitch of the staircase are aligned with the b axis. Between adjacent stacks, mol­ecules are related by a 21 axis and held in place by a herringbone-like network of additional inter­molecular C—H⋯O contacts of 2.35 Å.

1. Chemical context

Hy­droxy coumarins, such as 7-hy­droxy­coumarin (umbelliferone), are derivatives of common coumarin that posses hydroxyl groups, which enhance their solubility and biological activity (Kornicka et al., 2023). These compounds find use in the detection of toxins such as cyanide (Eapen et al., 2025), Hg2+ (Li et al., 2020), and Pb2+ (Sharma & Gulati, 2021). They exhibit a broad spectrum of pharmacological properties, including anti­oxidant, anti­coagulant, and anti­microbial activity, making them valuable in pharmaceutical research and applications (Kornicka et al., 2023; Lee et al., 2008).1.

In synthetic organic chemistry, the hy­droxy group of 7-hy­droxy­coumarin can be converted into an enhanced leaving group by reaction with triflic anhydride, thereby affording 2-oxo-2H-chromen-7-yl-tri­fluoro­methane­sulfonate, I. This triflate derivative is a highly activated electrophile, which can undergo cross-coupling (Zhang et al., 2007) or nucleophilic substitution to install diverse substituents on the coumarin core (Grimm & Lavis, 2011), expanding the structural and functional diversity for pharmaceutical and agrochemical exploration and for development of fluoro­phore-based imaging agents (Otsuka et al., 2016; López-Corrales et al., 2023).

2. Structural commentary

Fig. 1(a) presents a view of 2-oxo-2H-chromen-7-yl-tri­fluoro­methane­sulfonate that is orthogonal to the coumarin ring system, with atom labeling in accord with the IUPAC numbering system (Annunziata et al., 2020). The eleven atoms of the coumarin ring system are planar with a mean deviation of 0.021 Å. The maximum out-of-plane deviation is shown by O1 [0.039 (1) Å], as it is the only exocyclic atom of the parent structure. As seen in Fig. 1(b), O3 is bent slightly, but discernibly [0.173 (1) Å], to the upper face of the coumarin plane, while the triflate substituent as a whole is oriented downward toward the opposite (bottom) face. The C7—O3—S1—C1 torsion angle is 81.57 (15)°. The inter­atomic distances within the coumarin core of I are the same, within experimental resolution, as those observed in P21 (Zhang et al., 2021) and Pca21 (Waddell et al., 2024) polymorphs of coumarin itself.

Figure 1.

Figure 1

(a) Displacement ellipsoid plot (50% probability) of 2-oxo-2H-chromen-7-yl-tri­fluoro­methane­sulfonate, I, with complete atom labeling. (b) View of I along the edge of the coumarin plane. This perspective is from a position that is rotated by 90° from that shown in (a). Displacement ellipsoids are presented at the 50% probability level.

3. Supra­molecular features

The extended packing pattern of 2-oxo-2H-chromen-7-yl-tri­fluoro­methane­sulfonate mol­ecules begins with pseudo-coplanar pairs disposed around an inversion center and held in place, in part, via C8—H8⋯O2 close contacts of 2.38 Å (Table 1, Fig. 2). These dyads are arranged in a staircase-like fashion that places the top face of the coumarin ring system of one dyad member into a π–π stacking inter­action with the step above, while the bottom face of its centrosymmetric partner is similarly related to the dyad that forms the step below (Fig. 3). The π–π stacks are also formed around inversion centers, marked as red points in Fig. 3, a consequence of which is that the coumarin rings of different steps approach one another in a tail-to-tail manner but with a sideways slip that places carbon 9 of one mol­ecule above carbon 9 of its partner at a separation of 3.443 (2) Å. This distance is well within the 3.3-3.8 Å that is regarded as typical of offset parallel planar aromatic ring inter­actions (Janiak, 2000). The stair-like formations of dyads lie in the ab plane of the unit cell, with the b axis defining both the direction and the pitch of the staircase (Fig. 3).

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
C3—H3⋯O2i 0.95 2.35 3.267 (2) 162
C8—H8⋯O2ii 0.95 2.38 3.293 (2) 162

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Figure 2.

Figure 2

Pseudoplanar dyads of I formed by pairwise C8—H8⋯O2 inter­actions across an inversion center. The position of the inversion center is marked with a red point. Displacement ellipsoids are shown at 50%.

Figure 3.

Figure 3

View down the c axis of the cell showing the staircase-like arrangement of dyads of I along the b axis of the cell. Displacement ellipsoids are drawn at the 50% probability level. Red points designate the positions of inversion centers that relate each step of the staircase to its symmetry partners above and below. Displacement ellipsoids are drawn at the 50% level.

Between the staircase-like stacks of mol­ecules on the ab faces of the cell lie other stacks to which they are related by 21 axes. Fig. 4 illustrates how the mol­ecule bearing the S1B label is related by a 21 axis in red to the mol­ecules with the S1A and S1C labels. Similarly, this same mol­ecule is related to the mol­ecule with the S1D label by a c glide plane (in gray), which is parallel to the ac plane and orthogonal to the b axis (Fig. 4). A consequence of the positioning of 21 axis between adjacent stacks is that the coumarin mol­ecular planes in adjoining stacks have the same angular disposition of 26° relative to the stacking axis but in opposite directions (Fig. 5). Thus, when these stacks are considered from the perspective along the stacking axis, mol­ecules similarly eclipse one another without giving clear evidence of the alternating angle of cant between them (Fig. 6). Close contacts of 2.35 Å between C3–H3⋯O2 form the predominant inter­stack inter­actions (Table 1, Fig. 5). Although F1⋯F1 inter­molecular contacts of 2.863 (2) Å do occur (not illustrated), which is less than the 3.00 Å sum of the crystallographic van der Waals radii (Batsanov, 2001), the 139.97° C—F⋯F angle places this inter­action into the Type I category of nonstabilizing F⋯F inter­actions that is driven by the larger packing pattern (Reichenbächer et al., 2005).

Figure 4.

Figure 4

Partial packing of the unit cell for I showing mol­ecules related by 21 symmetry and by the c glide operation. Displacement ellipsoids are shown at 50%.

Figure 5.

Figure 5

View approximately along the ac face diagonal of the cell showing adjacent mol­ecular stacks in the direction of the b axis. Inter­molecular C3—H3⋯O2 close contacts are illustrated with dashed lines. Displacement ellipsoids are drawn at the 50% level.

Figure 6.

Figure 6

View down the b axis of the cell showing eclipsed columnar stacks of I. Displacement ellipsoids are shown at 50%.

4. Database survey

Related mol­ecules that have been identified structurally by X-ray crystallography are 4-tri­fluoro­methyl-7-tri­fluoro­methane­sulfonato-2H-chromen-2-one (Qin et al., 2025), 6,7-bis­(tri­fluoro­methane­sulphonato)-4-methyl-2H-chromen-2-one (Hamdy et al., 2016), 7-(4-meth­oxy­phen­yl)-4-methyl-6- tri­fluoro­methane­sulphonato-2H-chromen-2-one (Hamdy et al., 2016), and 6,7-bis­(tri­fluoro­methane­sulfonato)-3-bromo-4-methyl-2-oxo-2H-chromene (Hamdy et al., 2016).

5. Synthesis and crystallization

The starting material, 7-hy­droxy­coumarin (0.500 g, 3.08 mmol) was dissolved in dry THF (25 ml) under an N2 atmosphere and cooled to 273 K. Tri­ethyl­amine (1.1 ml, 7.70 mmol) was added to the reaction mixture. After stirring for 15 min at 273 K, triflic anhydride (0.57 ml, 3.39 mmol) was added dropwise. The reaction mixture was stirred at ambient temperature for 2 h, and progress of the reaction was monitored using thin-layer chromatography (TLC). The reaction mixture was extracted with EtOAc (50 ml) and H2O (25 ml). The organic layer was separated and dried over anyhdrous sodium sulfate. The solvent was evaporated under vacuum, and the crude product was purified by flash column chromatography on silica gel using 1:3 EtOAc:hexa­nes (v/v) as the eluant to yield the target compound as a white solid (0.810 g, 90% yield). Crystals were obtained by slow cooling of a warm solution in 2:1 EtOAc:hexa­nes (v/v). 1H NMR (300 MHz, δ, p.p.m. in CDCl3): 6.50 (d, J = 9.6 Hz, 1 H), 7.22–7.26 (m, 1 H), 7.27–7.30 (m, 1 H), 7.61 (d, J = 8.4 Hz, 1 H), 7.74 (d, J = 9.6 Hz, 1 H). 13C NMR (75 MHz, δ, p.p.m. in CDCl3): 110.5, 117.7, 177.8, 188.8, 120.3, 129.5, 142.1, 150.8, 154.6, 159.3.

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2. Hydrogen atoms were added in calculated positions and refined with isotropic displacement parameters that were approximately 1.2 times (for aromatic C—H) those of the carbon atoms to which they were attached. The C—H distance assumed was 0.95 Å.

Table 2. Experimental details.

Crystal data
Chemical formula C10H5F3O5S
M r 294.20
Crystal system, space group Monoclinic, C2/c
Temperature (K) 150
a, b, c (Å) 20.4767 (9), 6.0828 (3), 18.2181 (8)
β (°) 102.137 (2)
V3) 2218.45 (18)
Z 8
Radiation type Mo Kα
μ (mm−1) 0.35
Crystal size (mm) 0.17 × 0.06 × 0.03
 
Data collection
Diffractometer Bruker D8
Absorption correction Multi-scan (SADABS; Krause et al., 2015)
Tmin, Tmax 0.927, 0.988
No. of measured, independent and observed [I > 2σ(I)] reflections 28942, 3542, 2127
R int 0.069
(sin θ/λ)max−1) 0.725
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.044, 0.107, 1.04
No. of reflections 3542
No. of parameters 172
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.35, −0.37

Computer programs: APEX5 and SAINT (Bruker, 2024), SHELXT2018/2 (Sheldrick, 2015a), SHELXL2019/2 (Sheldrick, 2015b) and SHELXTL (Sheldrick, 2008).

Supplementary Material

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S205698902600071X/jy2068sup1.cif

e-82-00227-sup1.cif (888.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S205698902600071X/jy2068Isup2.hkl

e-82-00227-Isup2.hkl (283KB, hkl)

CCDC reference: 2525434

Additional supporting information: crystallographic information; 3D view; checkCIF report

supplementary crystallographic information

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Crystal data

C10H5F3O5S F(000) = 1184
Mr = 294.20 Dx = 1.762 Mg m3
Monoclinic, C2/c Mo Kα radiation, λ = 0.71073 Å
a = 20.4767 (9) Å Cell parameters from 4023 reflections
b = 6.0828 (3) Å θ = 3.4–25.5°
c = 18.2181 (8) Å µ = 0.35 mm1
β = 102.137 (2)° T = 150 K
V = 2218.45 (18) Å3 Block, colorless
Z = 8 0.17 × 0.06 × 0.03 mm

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Data collection

Bruker D8 diffractometer 3542 independent reflections
Radiation source: sealed tube 2127 reflections with I > 2σ(I)
Flat graphite monochromator Rint = 0.069
Detector resolution: 7.391 pixels mm-1 θmax = 31.0°, θmin = 2.3°
ω and φ scans h = −29→29
Absorption correction: multi-scan (SADABS; Krause et al., 2015) k = −8→8
Tmin = 0.927, Tmax = 0.988 l = −26→26
28942 measured reflections

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Refinement

Refinement on F2 Primary atom site location: intrinsic phasing
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.044 H-atom parameters constrained
wR(F2) = 0.107 w = 1/[σ2(Fo2) + (0.0376P)2 + 1.1073P] where P = (Fo2 + 2Fc2)/3
S = 1.04 (Δ/σ)max = 0.001
3542 reflections Δρmax = 0.35 e Å3
172 parameters Δρmin = −0.37 e Å3
0 restraints

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
S1 0.56456 (2) 0.72261 (8) 0.66170 (3) 0.03075 (14)
F1 0.52714 (6) 0.3963 (2) 0.57032 (6) 0.0431 (3)
F2 0.58390 (7) 0.3006 (2) 0.67780 (8) 0.0543 (4)
F3 0.48224 (7) 0.4049 (2) 0.66635 (8) 0.0565 (4)
O1 0.71324 (6) 0.4339 (2) 0.43122 (7) 0.0282 (3)
O2 0.76131 (8) 0.2925 (2) 0.34462 (8) 0.0412 (4)
O3 0.63257 (6) 0.7226 (2) 0.63519 (7) 0.0308 (3)
O4 0.51608 (7) 0.8532 (2) 0.61494 (9) 0.0426 (4)
O5 0.58160 (7) 0.7476 (2) 0.74031 (8) 0.0406 (4)
C1 0.53785 (10) 0.4375 (3) 0.64313 (11) 0.0322 (5)
C2 0.72999 (10) 0.4453 (3) 0.36176 (10) 0.0291 (4)
C3 0.70878 (10) 0.6384 (3) 0.31694 (11) 0.0316 (4)
H3 0.718411 0.649575 0.268294 0.038*
C4 0.67597 (9) 0.8014 (3) 0.34233 (11) 0.0306 (4)
H4 0.662584 0.926352 0.311571 0.037*
C5 0.62832 (10) 0.9553 (3) 0.44742 (12) 0.0322 (5)
H5 0.614123 1.084405 0.419228 0.039*
C6 0.61648 (10) 0.9353 (3) 0.51895 (12) 0.0324 (5)
H6 0.594656 1.048660 0.540455 0.039*
C7 0.63747 (9) 0.7445 (3) 0.55832 (10) 0.0258 (4)
C8 0.66927 (9) 0.5751 (3) 0.53042 (10) 0.0248 (4)
H8 0.682938 0.446113 0.558939 0.030*
C9 0.68042 (8) 0.6017 (3) 0.45848 (10) 0.0239 (4)
C10 0.66065 (9) 0.7901 (3) 0.41557 (11) 0.0262 (4)

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
S1 0.0284 (3) 0.0301 (3) 0.0362 (3) −0.0015 (2) 0.0125 (2) −0.0065 (2)
F1 0.0539 (8) 0.0436 (7) 0.0294 (7) −0.0069 (6) 0.0033 (6) −0.0088 (6)
F2 0.0619 (9) 0.0329 (7) 0.0562 (9) 0.0004 (6) −0.0148 (7) 0.0039 (6)
F3 0.0522 (8) 0.0631 (9) 0.0614 (9) −0.0282 (7) 0.0284 (7) −0.0191 (7)
O1 0.0372 (8) 0.0259 (7) 0.0233 (7) 0.0058 (6) 0.0103 (6) 0.0042 (6)
O2 0.0562 (10) 0.0418 (9) 0.0283 (8) 0.0135 (7) 0.0153 (7) 0.0012 (7)
O3 0.0243 (7) 0.0407 (8) 0.0289 (8) −0.0015 (6) 0.0088 (6) −0.0029 (6)
O4 0.0313 (8) 0.0391 (9) 0.0596 (11) 0.0098 (7) 0.0142 (7) 0.0059 (7)
O5 0.0439 (9) 0.0466 (9) 0.0349 (9) −0.0097 (7) 0.0166 (7) −0.0173 (7)
C1 0.0309 (11) 0.0362 (11) 0.0284 (11) −0.0047 (9) 0.0034 (9) −0.0028 (9)
C2 0.0306 (10) 0.0363 (11) 0.0198 (10) −0.0003 (9) 0.0042 (8) 0.0008 (8)
C3 0.0342 (11) 0.0381 (11) 0.0209 (10) −0.0031 (9) 0.0024 (8) 0.0061 (9)
C4 0.0284 (10) 0.0308 (10) 0.0298 (11) −0.0042 (8) −0.0003 (8) 0.0103 (8)
C5 0.0291 (10) 0.0237 (10) 0.0429 (13) 0.0000 (8) 0.0056 (9) 0.0083 (9)
C6 0.0313 (11) 0.0252 (10) 0.0424 (13) 0.0019 (8) 0.0119 (9) −0.0014 (9)
C7 0.0223 (9) 0.0302 (10) 0.0250 (10) −0.0028 (8) 0.0055 (8) −0.0011 (8)
C8 0.0232 (9) 0.0259 (10) 0.0249 (10) 0.0018 (7) 0.0043 (8) 0.0044 (8)
C9 0.0212 (9) 0.0234 (9) 0.0265 (10) −0.0002 (7) 0.0037 (7) 0.0005 (8)
C10 0.0210 (9) 0.0255 (9) 0.0298 (10) −0.0036 (7) 0.0002 (8) 0.0056 (8)

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Geometric parameters (Å, º)

S1—O5 1.4092 (15) C3—H3 0.9500
S1—O4 1.4094 (15) C4—C10 1.435 (3)
S1—O3 1.5671 (13) C4—H4 0.9500
S1—C1 1.829 (2) C5—C6 1.380 (3)
F1—C1 1.322 (2) C5—C10 1.395 (3)
F2—C1 1.316 (2) C5—H5 0.9500
F3—C1 1.310 (2) C6—C7 1.384 (3)
O1—C9 1.372 (2) C6—H6 0.9500
O1—C2 1.381 (2) C7—C8 1.372 (3)
O2—C2 1.207 (2) C8—C9 1.386 (2)
O3—C7 1.431 (2) C8—H8 0.9500
C2—C3 1.444 (3) C9—C10 1.398 (2)
C3—C4 1.334 (3)
O5—S1—O4 123.08 (9) C3—C4—H4 119.6
O5—S1—O3 105.48 (8) C10—C4—H4 119.6
O4—S1—O3 111.86 (8) C6—C5—C10 121.48 (18)
O5—S1—C1 106.92 (9) C6—C5—H5 119.3
O4—S1—C1 106.11 (10) C10—C5—H5 119.3
O3—S1—C1 101.16 (8) C5—C6—C7 117.77 (18)
C9—O1—C2 121.96 (14) C5—C6—H6 121.1
C7—O3—S1 123.46 (11) C7—C6—H6 121.1
F3—C1—F2 109.46 (18) C8—C7—C6 123.88 (17)
F3—C1—F1 108.86 (16) C8—C7—O3 115.41 (16)
F2—C1—F1 108.22 (17) C6—C7—O3 120.45 (16)
F3—C1—S1 109.27 (14) C7—C8—C9 116.58 (17)
F2—C1—S1 110.80 (13) C7—C8—H8 121.7
F1—C1—S1 110.20 (14) C9—C8—H8 121.7
O2—C2—O1 116.49 (17) O1—C9—C8 116.47 (15)
O2—C2—C3 126.38 (18) O1—C9—C10 120.92 (16)
O1—C2—C3 117.13 (17) C8—C9—C10 122.60 (17)
C4—C3—C2 121.47 (18) C5—C10—C9 117.68 (17)
C4—C3—H3 119.3 C5—C10—C4 124.61 (17)
C2—C3—H3 119.3 C9—C10—C4 117.70 (17)
C3—C4—C10 120.76 (18)
O5—S1—O3—C7 −167.17 (14) C5—C6—C7—C8 0.1 (3)
O4—S1—O3—C7 −31.00 (16) C5—C6—C7—O3 173.90 (17)
C1—S1—O3—C7 81.57 (15) S1—O3—C7—C8 −121.98 (16)
O5—S1—C1—F3 66.41 (16) S1—O3—C7—C6 63.7 (2)
O4—S1—C1—F3 −66.57 (16) C6—C7—C8—C9 0.1 (3)
O3—S1—C1—F3 176.56 (13) O3—C7—C8—C9 −173.99 (15)
O5—S1—C1—F2 −54.27 (17) C2—O1—C9—C8 −176.98 (16)
O4—S1—C1—F2 172.75 (14) C2—O1—C9—C10 2.0 (3)
O3—S1—C1—F2 55.87 (16) C7—C8—C9—O1 178.91 (15)
O5—S1—C1—F1 −174.02 (13) C7—C8—C9—C10 0.0 (3)
O4—S1—C1—F1 53.00 (16) C6—C5—C10—C9 0.4 (3)
O3—S1—C1—F1 −63.87 (15) C6—C5—C10—C4 −178.56 (18)
C9—O1—C2—O2 176.94 (16) O1—C9—C10—C5 −179.14 (16)
C9—O1—C2—C3 −2.8 (2) C8—C9—C10—C5 −0.2 (3)
O2—C2—C3—C4 −177.9 (2) O1—C9—C10—C4 −0.1 (3)
O1—C2—C3—C4 1.7 (3) C8—C9—C10—C4 178.84 (17)
C2—C3—C4—C10 0.1 (3) C3—C4—C10—C5 178.07 (19)
C10—C5—C6—C7 −0.4 (3) C3—C4—C10—C9 −0.9 (3)

2-Oxo-2H-chromen-7-yl trifluoromethanesulfonate . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C3—H3···O2i 0.95 2.35 3.267 (2) 162
C8—H8···O2ii 0.95 2.38 3.293 (2) 162

Symmetry codes: (i) −x+3/2, y+1/2, −z+1/2; (ii) −x+3/2, −y+1/2, −z+1.

Funding Statement

This work was supported by the Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant No. P20GM103424-21, by the National Institute of General Medical Sciences of the National Institutes of Health under award No. R16GM149412, and by the National Science Foundation under award No. NSF-2315727 in collaboration with Professor Dorin Boldor of Louisiana State University. The National Science Foundation (MRI: 1228232) is thanked for funding the purchase of Tulane University’s Bruker D8 Quest diffractometer with Photon 3 CPAD detector and for support of this project (CHE: 1836589). Tulane University is acknowledged for its ongoing assistance with operational costs for its X-ray diffraction facility.

References

  1. Annunziata, F., Pinna, C., Dallavalle, S., Tamborini, L. & Pinto, A. (2020). Int. J. Mol. Sci.21, 4618. [DOI] [PMC free article] [PubMed]
  2. Batsanov, S. S. (2001). Inorg. Mater.37, 871–885.
  3. Bruker (2024). APEX5 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
  4. Eapen, A. K., Das, D., Sutradhar, S., Sarkar, P. & Ghosh, B. N. (2025). J. Mol. Struct.1337, 142188.
  5. Grimm, J. B. & Lavis, L. D. (2011). Org. Lett.13, 6354–6357. [DOI] [PMC free article] [PubMed]
  6. Hamdy, A. M., Khaddour, Z., Al-Masoudi, N. A., Rahman, Q., Hering-Junghans, C., Villinger, A. & Langer, P. (2016). Bioorg. Med. Chem.24, 5115–5126. [DOI] [PubMed]
  7. Janiak, C. (2000). J. Chem. Soc. Dalton Trans. pp. 3885–3896.
  8. Kornicka, A., Balewski, L., Lahutta, M. & Kokoszka, J. (2023). Pharmaceuticals16, 1732. [DOI] [PMC free article] [PubMed]
  9. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  10. Lee, K.-S., Kim, H.-J., Kim, G.-H., Shin, I. & Hong, J.-I. (2008). Org. Lett.10, 49–51. [DOI] [PubMed]
  11. Li, X., Duan, Q., Yu, Y., Wang, K., Zhu, H., Zhang, X., Liu, C., Jia, P., Li, Z., Sheng, W. & Zhu, B. (2020). Luminescence35, 941–946. [DOI] [PubMed]
  12. López-Corrales, M., Rovira, A., Gandioso, A., Nonell, S., Bosch, M. & Marchán, V. (2023). J. Org. Chem.88, 7128–7140. [DOI] [PMC free article] [PubMed]
  13. Otsuka, Y., Sasaki, A., Teshima, T., Yamada, K. & Yamamoto, T. (2016). Org. Lett.18, 1338–1341. [DOI] [PubMed]
  14. Qin, X., Li, Y., Song, R., Wang, L. & Ye, B. (2025). Z. Kristallogr. New Cryst. Struct.240, 523–526.
  15. Reichenbächer, K., Süss, K. I. & Hulliger, J. (2005). Chem. Soc. Rev.34, 22–30. [DOI] [PubMed]
  16. Sharma, N. & Gulati, A. (2021). Luminescence36, 1172–1180. [DOI] [PubMed]
  17. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  18. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  19. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  20. Waddell, P. G., Probert, M. R. & Johnson, N. T. (2024). J. Chem. Educ.101, 4276–4281.
  21. Zhang, K., Sun, C. C., Liu, Y., Wang, C., Shi, P., Xu, J., Wu, S. & Gong, J. (2021). Chem. Mater.33, 1053–1060.
  22. Zhang, L., Meng, T., Fan, R. & Wu, J. (2007). J. Org. Chem.72, 7279–7286. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S205698902600071X/jy2068sup1.cif

e-82-00227-sup1.cif (888.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S205698902600071X/jy2068Isup2.hkl

e-82-00227-Isup2.hkl (283KB, hkl)

CCDC reference: 2525434

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES